[ET Net News Agency, 4 November 2026] GENSCRIPT B-1K (01548) rose 10.7% to HK$33.46.
It hits an intra-day high of HK$33.46, and an intra-day low of HK$29.6. The total shares traded was 43.6 million, with a value of HK$1.36b. The active buy/sell ratio is 56:44, with net buying turnover of HK$161.85m. CLSA LTD accounts for greatest net responsive buying turnover of HK$28.49m, with volume weighted average price of HK$29.952. MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$59.19m, with volume weighted average price of HK$30.672.
Basic Information| Nominal | 33.460 | % Chg | +10.72% |
| High | 33.460 | Low | 29.600 |
| Shares Tr | 43.6m | Turnover | 1.36b |
| 10-D SMA | 33.804 | %H.V | 121.361 |
| 20-D SMA | 35.460 | VWAP | 31.160 |
| 50-D SMA | 36.724 | RSI14 | 46.354 |
Status: Active buy/sell ratio is 56:44, with net buying turnover of HK$161.85m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| GENSCRIPT B-1K (01548) | 33.46 | +10.72 |
| INNOVENT BIO (01801) | 84.05 | +5.92 |
| XTALPI (02228) | 6.04 | +3.25 |
| WUXI XDC (02268) | 71.10 | +12.15 |
| WUXI BIO (02269) | 48.00 | +11.47 |
| WUXI APPTEC (02359) | 196.90 | +11.88 |
| BEONE MEDICINES (06160) | 228.80 | +8.85 |
| SKB BIO (06990) | 436.60 | +8.72 |
| AKESO (09926) | 81.80 | +6.10 |
| REMEGEN (09995) | 68.90 | +10.15 |
(ed)
Nominal 
